Stock IGMS IGM BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases IGM Biosciences, Inc.

Equities

IGMS

US4495851085

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-25 EDT 		5-day change 1st Jan Change
6.83 USD -6.44% Intraday chart for IGM Biosciences, Inc. -5.66% -17.81%
05-09 RBC Cuts Price Target on IGM Biosciences to $20 From $21, Keeps Outperform, Speculative Risk MT
05-08 Earnings Flash (IGMS) IGM BIOSCIENCES Posts Q1 Collaboration Revenue $497,000 MT

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
IGM Biosciences to Present at the Jefferies Healthcare Conference
GL
Treatment.com AI Inc. (TRUE.CN) Advances AI in Healthcare with Strategic Moves
AQ
IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
GL
IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference
GL
IGM Biosciences Announces Refocusing of Sanofi Collaboration
GL
IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
GL
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
GL
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
AQ
MEDIVIR AB - YEAR-END REPORT JANUARY - DECEMBER 2023
AQ
IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
GL
IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
AQ
IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
GL
Medivir's partner IGM Biosciences announces strategic pipeline prioritization to extend its cash runway
AQ
IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension
GL
Bulletin from Extraordinary General Meeting in Medivir AB (publ)
PR
Medivir to present at the Erik Penser Bank Company Event
PR
IGM Biosciences Announces Third Quarter 2023 Financial Results
GL
IGM Biosciences to Present at Two Upcoming Investor Conferences
GL
Change in Medivir's Board of Directors
AQ
Medivir AB - Fostrox + Lenvima continues to show promising tumor control in HCC, all patients have now dosed at least two treatment cycles
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IGMS Stock
  4. News IGM Biosciences, Inc.
  5. Press Releases